Latest MedWatch Safety Alert: Significant Concern for Workers’ Compensation
December 30, 2019
The U.S. Food and Drug Administration (FDA) recently released a MedWatch Safety Alert regarding serious concerns around the use of gabapentinoids and the risk of serious breathing problems for patients who have respiratory risk factors, as well as those utilizing opioids or any other medications...
Learn more